Skip to main content
. Author manuscript; available in PMC: 2018 Aug 13.
Published in final edited form as: Cerebellum. 2017 Aug;16(4):786–791. doi: 10.1007/s12311-017-0853-x

Table 1.

Clinical and pathological features of controls and ET cases

Variables Controls ET cases p value
n 30 60
Age at death (years) 85.2 ± 5.7 86.0 ± 6.6 0.57b
Age of tremor onset (years) NA 44.0 ± 21.6 NA
Median = 47.5
Duration of symptoms (years) NA 42.0 ± 21.5 NA
Median = 39.0
Gender 0.23c
 Male 15 (50.0%) 22 (36.7%)
 Female 15 (50.0%) 38 (63.3%)
Total tremor scores NA 12.45 ± 3.19 NA
Purkinje cell countsa 10.52 ± 1.49 8.82 ± 1.48 <0.001b
Torpedo counts 3.90 ± 3.28 15.38 ± 15.02 <0.001d
Median = 3.00 Median = 12.00
Heterotopic Purkinje cell counts 6.23 ± 11.45 7.65 ± 9.14 0.020d
Median = 2.00 Median = 4.50
Hairy basket ratings 1.57 ± 0.61 2.00 ± 0.78 0.004d
Median = 1.50 Median = 2.00
Purkinje cell axonal recurrent collateral counts 1.01 ± 1.16 1.88 ± 1.53 0.006d
Median = 0.60 Median = 1.42
Purkinje cell thickened axonal profile counts 0.96 ± 1.60 1.76 ± 2.32 0.017d
Median = 0.55 Median = 1.09
Purkinje cell axonal branching counts 0.09 ± 0.10 0.37 ± 0.40 <0.001d
Median = 0.07 Median = 0.27

Values represent mean ± standard deviation or number (percentage), and for variables with non-normal distribution, the median is reported as well

NA not applicable

a

Mean number of Purkinje cell counts (PCs) per ×100 microscopic field, among 15 sampled fields

b

Independent samples t test

c

Chi-square test

d

Independent samples Mann-Whitney U test

The italicized entries are statistically significant